|Day Low/High||5.20 / 5.25|
|52 Wk Low/High||2.84 / 5.21|
Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Jive Software, Inc.
Here are Tuesday's top research calls, including new coverage of Adobe and Okta, a downgrade for Advanced Micro Devices and an upgrade for Chegg.
Wave Systems will pay $5.25 per share for the company.
We exited one position and downgraded another as earnings season heated up.
We added a new name to the portfolio as the market took a breather in a shortened trading week.
We beat the benchmark Russell 2000 for the quarter, and we await a busy week on the economic front.
We are keeping an eye on rate-sensitive names for possible buying opportunities, as stocks fell around 1.5% this week.
We picked up more Abraxas Petroleum on weakness, while the market rebounded slightly after the FOMC announced the anticipated quarter-point rate hike.
We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.
We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.
We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
The stock is up nearly 11% after management delivered better-than-expected quarterly results.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
This week we'll get regional economic and housing data, a GDP report plus fourth-quarter earnings.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.